Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 4, 2014, Pages 414-420

  Aun, Marcelo Vivolo ^a   Blanca, Miguel ^b   Garro, Laila Sabino ^a   Ribeiro, Marisa Rosimeire ^a   Kalil, Jorge ^a   Motta, Antonio Abilio ^a   Castells, Mariana ^c   Giavina Bianchi, Pedro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adverse drug reaction; Anaphylaxis; Epinephrine; Hypertensively reaction; IgE mediated; Nonsteroidal anti inflammatory drugs

Indexed keywords

ADRENALIN; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; ALLERGEN;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; ASTHMA; ATOPY; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ASSESSMENT; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; SCREENING; BLOOD; COMPLICATION; EMERGENCY HEALTH SERVICE; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLERGENS; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; EMERGENCY MEDICAL SERVICES; EPINEPHRINE; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84904063399     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.03.014     Document Type: Article

References (34)

1. Johansson S.G.O., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization. JAllergy Clin Immunol 2004, 113:832-836.
2. Pichler W.J., Adam J., Daubner B., Gentinetta T., Keller M., Yerly D. Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Medical Clin North Am 2010, 94:645-664.
3. Romano A., Torres M.J., Castells M., Sanz M.L., Blanca M. Diagnosis and management of drug hypersensitivity reactions. JAllergy Clin Immunol 2011, 127:S67-S73.
4. Simons F.E.R., Ardusso L.R.F., Bilò M.B., El-Gamal Y.M., Ledford D.K., Ring J., et al. World Allergy Organization anaphylaxis guidelines: summary. JAllergy Clin Immunol 2011, 127:587-593.e22.
5. Cox L., Larenas-Linnemann D., Lockey R.F., Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. JAllergy Clin Immunol 2010, 125:569-574.e7.
6. Techapornroong M., Akrawinthawong K., Cheungpasitporn W., Ruxrungtham K. Anaphylaxis: a ten years inpatient retrospective study. Asian Pac J Allergy Immunol 2010, 28:262-269.
7. Liew W.K., Williamson E., Tang M.L.K. Anaphylaxis fatalities and admissions in Australia. JAllergy Clin Immunol 2009, 123:434-442.
8. Beyer K., Eckermann O., Hompes S., Grabenhenrich L., Worm M. Anaphylaxis inan emergency setting: elicitors, therapy and incidence of severe allergic reactions. Allergy 2012, 67:1451-1456.
9. Grabenhenrich L., Hompes S., Gough H., Ruëff F., Scherer K., Pföhler C., et al. Implementation of anaphylaxis management guidelines: a register-based study. PLoS One 2012, 7:e35778.
10. Antunez C., Fernandez T., Blanca-Lopez N., Torres M.J., Mayorga C., Canto G., et al. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response. Allergy 2006, 61:940-946.
11. Mertes P.M., Alla F., Tréchot P., Auroy Y., Jougla E. Anaphylaxis during anesthesia in France: an 8-year national survey. JAllergy Clin Immunol 2011, 128:366-373.
12. Torres M.J., Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010, 94:805-820.
13. Farnam K., Chang C., Teuber S., Gershwin M.E. Nonallergic drug hypersensitivity reactions. Int Arch Allergy Immunol 2012, 159:327-345.
14. Laroche D., Namour F., Lefrancois C., Aimone-Gastin I., Romano A., Sainte-Laudy J., et al. Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy 1999, 54(Suppl 58):13-16.
15. Kowalski M.L., Makowska J.S., Blanca M., Bavbek S., Bochenek G., Bousquet J., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs): classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*. Allergy 2011, 66:818-829.
16. Simons F.E.R., Ardusso L.R.F., Bilò M.B., Dimov V., Ebisawa M., El-Gamal Y.M., et al. 2012 update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012, 12:389-399.
17. Demoly P., Kropf R., Bircher A., Pichler W.J. Drug hypersensitivity: questionnaire. Allergy 1999, 54:999-1003.
18. Torres M.J., Blanca M., Fernandez J., Romano A., Weck A., Aberer W., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003, 58:961-972.
19. Mertes P.M., Malinovsky J.M., Jouffroy L., Aberer W., Terreehorst I., Brockow K., et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. JInvestig Allergol Clin Immunol 2011, 21:442-453.
20. Aberer W., Bircher A., Romano A., Blanca M., Campi P., Fernandez J., et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58:854-863.
21. Messaad D., Sahla H., Benahmed S., Godard P., Bousquet J., Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004, 140:1001-1006.
22. Aun M.V., Bisaccioni C., Garro L.S., Rodrigues A.T., Tanno L.K., Ensina L.F.C., et al. Outcomes and safety of drug provocation tests. Allergy Asthma Proc 2011, 32:301-306.
23. Mita H., Tadokoro K., Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998, 53:1133-1140.
24. Thong B.Y.-H., Tan T.-C. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011, 71:684-700.
25. Doña I., Blanca-Lopez N., Jagemann L.R., Torres M.J., Rondon C., Campo P., et al. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011, 66:1428-1433.
26. Sala-Cunill A., Cardona V., Labrador-Horrillo M., Luengo O., Esteso O., Garriga T., et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013, 160:192-199.
27. Doña I., Blanca-López N., Cornejo-García J.A., Torres M.J., Laguna J.J., Fernández J., et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011, 41:86-95.
28. Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000, 30:1144-1150.
29. Renaudin J.M., Beaudouin E., Ponvert C., Demoly P., Moneret-Vautrin D.A. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 2013, 68:929-937.
30. Antunez C., Martin E., Cornejo-Garcia J.A., Blanca-Lopez N., R-Pena R., Mayorga C., et al. Immediate hypersensitivity reactions to penicillins and other betalactams. Curr Pharm Des 2006, 12:3327-3333.
31. Doña I., Blanca-Lopez N., Torres M.J., García-Campos J., García-Núñez I., Gómez F., et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. JInvestig Allergol Clin Immunol 2012, 22:363-371.
32. Viola M., Rumi G., Valluzzi R.L., Gaeta F., Caruso C., Romano A. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011, 41:96-103.
33. Blanca-Lopez N., Torres M.J., Doña I., Campo P., Rondón C., Seoane Reula M.E., et al. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013, 43:85-91.
34. Campo P., Ayuso P., Salas M., Plaza M.C., Cornejo-García J.A., Doña I., et al. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. Allergy 2013, 68:1001-1007.